Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | Insights into the treatment and management of advanced systemic mastocytosis

Deepti Radia, MBBS, BSc, MRCPI, FRCPath, MSc Med Ed, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses the treatment and management of advanced systemic mastocytosis (SM) and how the field has transformed in recent years. Dr Radia first highlights novel agents that have made an impact, drawing focus on tyrosine kinase inhibitors (TKIs), and then goes on to discuss the challenge of treating overlap syndromes and how these may be overcome. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Advisory Board and Honoraria: Novartis, Consultant and Honoraria: Blueprint Medicines, Cogent Biosciences.
Study response adjudication committees : EXPLORER/PATHFINDER – Blueprint Medicines and APEX -Cogent Biosciences.